Theodore Zhang1, Jordan Dunson1, Fasiha Kanwal2, Nhu Thao Nguyen Galvan3, John M Vierling4, Christine O'Mahony5, John A Goss5, Abbas Rana3. 1. Department of Student Affairs, Baylor College of Medicine, Houston, Texas. 2. Michael E. DeBakey Department of Medicine, Baylor College of Medicine, Houston, Texas. 3. Division of Abdominal Transplantation, Michael E. DeBakey Department of General Surgery, Baylor College of Medicine, Houston, Texas. 4. Division of Gastroenterology, Nutrition, and Hepatology, Baylor College of Medicine, Houston, Texas. 5. Liver Center, Division of Abdominal Transplantation, Department of General Surgery, Baylor College of Medicine, Houston, Texas.
Abstract
IMPORTANCE: Investigating outcomes after marginal allograft transplant is essential in determining appropriate and more aggressive use of these allografts. OBJECTIVE: To determine the time trends in the outcomes of marginal liver allografts as defined by 6 different sets of criteria. DESIGN, SETTING, AND PARTICIPANTS: In this case-control, multicenter study, 75 050 patients who received a liver transplant between March 1, 2002, and September 30, 2016, were retrospectively analyzed to last known follow-up (n = 55 395) or death (n = 19 655) using the United Network for Organ Sharing Database. The study period was divided into three 5-year eras: 2002-2006, 2007-2011, and 2012-2016. Kaplan-Meier survival analysis with log-rank test and Cox proportional hazards regression analysis were used to examine the allograft after transplant with marginal allografts, which were defined as 90th percentile Donor Risk Index allografts (calculated over the entire study period), donor after circulatory death allografts, national share allografts, old age (donors >70 years) allografts, fatty liver allografts, and 90th percentile Discard Risk Index allografts. Statistical analysis was performed from August to December 2019. MAIN OUTCOMES AND MEASURES: Allograft failure after transplant as defined by the Organ Procurement and Transplantation Network database. RESULTS: Among the 75 050 patients (44 394 men; mean [SD] age, 54.3 [9.9] years) in the study, Donor Risk Index, patient Model for End-stage Liver Disease scores, and balance of risk scores significantly increased over time. Multivariate Cox proportional hazards regression analysis indicated that 90th percentile Donor Risk Index allograft survival increased across the study period (2002-2006: hazard ratio, 1.41 [95% CI, 1.34-1.49]; 2007-2011: hazard ratio, 1.25 [95% CI, 1.17-1.34]; 2012-2016: hazard ratio, 1.10 [95% CI, 0.98-1.24]). Secondary definitions of marginal allografts (donor after circulatory death, national share, old age donors, fatty liver, and 90th percentile Discard Risk Index) showed similar improvements in allograft survival. CONCLUSIONS AND RELEVANCE: The study's findings encourage the aggressive use of liver allografts and may indicate a need for a redefinition of allograft marginality in liver transplantation.
IMPORTANCE: Investigating outcomes after marginal allograft transplant is essential in determining appropriate and more aggressive use of these allografts. OBJECTIVE: To determine the time trends in the outcomes of marginal liver allografts as defined by 6 different sets of criteria. DESIGN, SETTING, AND PARTICIPANTS: In this case-control, multicenter study, 75 050 patients who received a liver transplant between March 1, 2002, and September 30, 2016, were retrospectively analyzed to last known follow-up (n = 55 395) or death (n = 19 655) using the United Network for Organ Sharing Database. The study period was divided into three 5-year eras: 2002-2006, 2007-2011, and 2012-2016. Kaplan-Meier survival analysis with log-rank test and Cox proportional hazards regression analysis were used to examine the allograft after transplant with marginal allografts, which were defined as 90th percentile Donor Risk Index allografts (calculated over the entire study period), donor after circulatory death allografts, national share allografts, old age (donors >70 years) allografts, fatty liver allografts, and 90th percentile Discard Risk Index allografts. Statistical analysis was performed from August to December 2019. MAIN OUTCOMES AND MEASURES: Allograft failure after transplant as defined by the Organ Procurement and Transplantation Network database. RESULTS: Among the 75 050 patients (44 394 men; mean [SD] age, 54.3 [9.9] years) in the study, Donor Risk Index, patient Model for End-stage Liver Disease scores, and balance of risk scores significantly increased over time. Multivariate Cox proportional hazards regression analysis indicated that 90th percentile Donor Risk Index allograft survival increased across the study period (2002-2006: hazard ratio, 1.41 [95% CI, 1.34-1.49]; 2007-2011: hazard ratio, 1.25 [95% CI, 1.17-1.34]; 2012-2016: hazard ratio, 1.10 [95% CI, 0.98-1.24]). Secondary definitions of marginal allografts (donor after circulatory death, national share, old age donors, fatty liver, and 90th percentile Discard Risk Index) showed similar improvements in allograft survival. CONCLUSIONS AND RELEVANCE: The study's findings encourage the aggressive use of liver allografts and may indicate a need for a redefinition of allograft marginality in liver transplantation.
Authors: David A Axelrod; Mary K Guidinger; Keith P McCullough; Alan B Leichtman; Jeffrey D Punch; Robert M Merion Journal: Am J Transplant Date: 2004-06 Impact factor: 8.086
Authors: J M Garonzik-Wang; N T James; K J Van Arendonk; N Gupta; B J Orandi; E C Hall; A B Massie; R A Montgomery; N N Dagher; A L Singer; A M Cameron; D L Segev Journal: Am J Transplant Date: 2013-02-15 Impact factor: 8.086
Authors: Philipp Dutkowski; Christian E Oberkofler; Ksenija Slankamenac; Milo A Puhan; Erik Schadde; Beat Müllhaupt; Andreas Geier; Pierre A Clavien Journal: Ann Surg Date: 2011-11 Impact factor: 12.969
Authors: John F Renz; Cindy Kin; Milan Kinkhabwala; Dominique Jan; Rhaghu Varadarajan; Michael Goldstein; Robert Brown; Jean C Emond Journal: Ann Surg Date: 2005-10 Impact factor: 12.969
Authors: S Feng; N P Goodrich; J L Bragg-Gresham; D M Dykstra; J D Punch; M A DebRoy; S M Greenstein; R M Merion Journal: Am J Transplant Date: 2006-04 Impact factor: 8.086
Authors: A Rana; M A Hardy; K J Halazun; D C Woodland; L E Ratner; B Samstein; J V Guarrera; R S Brown; J C Emond Journal: Am J Transplant Date: 2008-09-25 Impact factor: 8.086
Authors: Aaron M Delman; Kevin M Turner; Allison M Ammann; Emily Schepers; Dennis M Vaysburg; Alex R Cortez; Robert M Van Haren; Greg C Wilson; Shimul A Shah; Ralph C Quillin Journal: Clin Transplant Date: 2022-04-25 Impact factor: 3.456
Authors: Samantha E Halpern; Mariya L Samoylova; Brian I Shaw; Samuel J Kesseli; Matthew G Hartwig; Yuval A Patel; Lisa M McElroy; Andrew S Barbas Journal: Transplant Direct Date: 2021-08-06
Authors: Ethan Chan; April J Logan; Jeffrey M Sneddon; Navdeep Singh; Guy N Brock; William K Washburn; Austin D Schenk Journal: Am J Transplant Date: 2022-03-09 Impact factor: 9.369
Authors: Simon Moosburner; Igor M Sauer; Frank Förster; Thomas Winklmann; Joseph Maria George Vernon Gassner; Paul V Ritschl; Robert Öllinger; Johann Pratschke; Nathanael Raschzok Journal: Hepatol Commun Date: 2020-12-05